These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 686909)

  • 1. Antihypertensive effects of delta9-tetrahydrocannabinol.
    Kosersky DS
    Arch Int Pharmacodyn Ther; 1978 May; 233(1):76-81. PubMed ID: 686909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat.
    Adams MD; Earnhardt JT; Dewey WL; Harris LS
    J Pharmacol Exp Ther; 1976 Mar; 196(3):649-56. PubMed ID: 4606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance development to the effect of delta9-tetrahydrocannabinol on conditioned behavior: role of treatment interval and influence of microsomal metabolism.
    Davis WM; Borgen LA
    Arch Int Pharmacodyn Ther; 1975 Jan; 213(1):97-112. PubMed ID: 1156021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. delta9-Tetrahydrocannabinol: tolerance after noncontingent exposure in rats.
    Järbe TU
    Arch Int Pharmacodyn Ther; 1978 Jan; 231(1):49-56. PubMed ID: 637625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat.
    Adams MD; Chait LD; Earnhardt JT
    Br J Pharmacol; 1976 Jan; 56(1):43-8. PubMed ID: 1252665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of delta9-thc induced hypothermia in rats.
    Schmeling WT; Hosko MJ
    Arch Int Pharmacodyn Ther; 1977 Jun; 227(2):302-8. PubMed ID: 907415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomic and cardiovascular effects of chronic delta9-tetrahydrocannabinol administration in mongrel dogs.
    Jandhyala BS; Buckley JP
    Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):593-607. PubMed ID: 193167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic administration of delta9-tetrahydrocannabinol on the heart rate of mongrel dogs.
    Jandhyala BS; Malloy KP; Buckley JP
    Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):201-4. PubMed ID: 935652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic, heart rate, and temperature effects of delta8-THC during acute and chronic administration to conscious rats.
    Hine B; Toreelio M; Gershon S
    Pharmacology; 1977; 15(1):63-72. PubMed ID: 14347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated administration with Delta9-tetrahydrocannabinol regulates mu-opioid receptor density in the rat brain.
    Corchero J; Oliva JM; García-Lecumberri C; Martin S; Ambrosio E; Manzanares J
    J Psychopharmacol; 2004 Mar; 18(1):54-8. PubMed ID: 15107185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cardiovascular and autonomic effects of repeated administration of delta-9-tetrahydrocannabinol to rhesus monkeys.
    Fredericks AB; Benowitz NL; Savanapridi CY
    J Pharmacol Exp Ther; 1981 Feb; 216(2):247-53. PubMed ID: 6257883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profound hypothermia in mammals treated with tetrahydrocannabinols, morphine, or chlorpromazine.
    Haavik CO
    Fed Proc; 1977 Nov; 36(12):2595-8. PubMed ID: 913617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propofol sedation is reduced by delta9-tetrahydrocannabinol in mice.
    Brand PA; Paris A; Bein B; Meybohm P; Scholz J; Ohnesorge H; Tonner PH
    Anesth Analg; 2008 Jul; 107(1):102-6. PubMed ID: 18635473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol.
    Lemberger L; Martz R; Rodda B; Forney R; Rowe H
    J Clin Invest; 1973 Oct; 52(10):2411-7. PubMed ID: 4729039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and subchronic influences of tetrahydrocannabinols on water and food intake, body weight, and temperature in rats.
    Johansson JO; Jarbe TU; Henriksson BG
    TIT J Life Sci; 1975; 5(1-2):17-27. PubMed ID: 1188935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing the selectivity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol: complete substitution with methanandamide.
    Alici T; Appel JB
    Pharmacol Biochem Behav; 2004 Nov; 79(3):431-7. PubMed ID: 15582014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of the enhancement and restoration of the analgesic efficacy of codeine and morphine by delta9-tetrahydrocannabinol.
    Williams IJ; Edwards S; Rubo A; Haller VL; Stevens DL; Welch SP
    Eur J Pharmacol; 2006 Jun; 539(1-2):57-63. PubMed ID: 16687136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive and diuretic effects of NZ-105, a novel dihydropyridine derivative.
    Masuda Y; Takeguchi M; Arakawa C; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1990; 304():247-64. PubMed ID: 2241414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta9-THC as a discriminative cue in pigeons: effects of delta8-THC, CBD, and CBN.
    Järbe TU; Henriksson BG; Ohlin GC
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):68-72. PubMed ID: 921403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of repeated administration of delta9-tetrahydrocannabinol on serotonin metabolism in the rat brain.
    Sofia RD; Dixit BN; Barry H
    Arch Int Pharmacodyn Ther; 1977 Sep; 229(1):52-8. PubMed ID: 931467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.